Move over Botox and Dysport, here comes some competition!  Xeomin (incobotulinumtoxinA) was recently approved by the FDA for cosmetic use.  Xeomin has been widely used in the past to treat cervical dystonia and blepharospasm.  With the recent FDA approval it can now be used to treat frown lines.  Xeomin is manufactured by Merz Aesthetics, the same company that manufactures Radiesse dermal filler.  Xeomin doesn’t contain the same complex proteins as its competitors, which could potentially decrease the risk of certain side effects.